Pediatr. praxi. 2011;12(6):425-426

Lichen sclerosus et atrophicus in children

MUDr.Jana Valíčková1, MUDr.Hana Bučková, Ph.D.1, prof.MUDr.Zdeněk Doležel, CSc.2
1 Dětské kožní oddělení, Pediatrická klinika FN Brno
2 Pediatrická klinika LF MU a FN Brno

Lichen sclerosus et atrophicus, balanitis xerotica obliterans in boys, is a chronic skin disease with genital predilection. The clinical symptoms

are not specific and making correct diagnosis usually takes several months. Invasive examinations without exact diagnose are common. The

correct diagnostic and treatment prevent permanent genital atrophy. The recurrences are frequent and long term follow up is necessary.

Keywords: lichen sclerosus et atrophicus, balanitis xerotica obliterans, autoimunne disease

Published: December 10, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Valíčková J, Bučková H, Doležel Z. Lichen sclerosus et atrophicus in children. Pediatr. praxi. 2011;12(6):425-426.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Harper J, Oranje A, Prose N. Textbook of Pediatric Dermatology. Blackwell Publishing 2006: 1822-1825.
    2. Paller A, Mancini AJ. Hurwitz clinical pediatric dermatology. Elsevier Saunders 2006: 599-600.
    3. Kiss A, Király L, Kutasy B, et al. High incidence of balanitis xerotica obliterans in boys with phimosis: prospective 10-year study. Pediatr Dermatol 2010; 22(4): 305-308. Go to original source... Go to PubMed...
    4. Chandra N, Gurcharan S. Neonatal lichen sclerosus. Int. J. Dermatol 2008; 47(6): 645-647. Go to original source...
    5. Marren P, Yell J, Charnock FM, et al. The association between lichen sclerosus and antigens of the HLA system. Br J Dermatol 1995; 132(2): 197-203. Go to original source... Go to PubMed...
    6. Tchorzewski H, Rotsztejn H, Banasik M, et al. The involvement of immunoregulatory T cells in the pathogenesis of Lichen Sclerosus. Med Sci Monit 2005; 11(1): 39-43.
    7. Kowalewski C, Kozlowska A, Chan I, et al. Three-dimensional imaging reveals major changes in skin microvasculature in lipoid proteinosis and lichen sclerosus. J Dermatos Sci 2005; 38(3): 215-224. Go to original source... Go to PubMed...
    8. Chan I. The role of extracellular matrix protein 1 in human skin. Clin exp dermatol 2004; 29(1): 52-56. Go to original source... Go to PubMed...
    9. Goldstein AT, Marinoff SC, Christopher K. Pimecrolimus for the treatment of vulvar lichen sclerosus in a premenarchal girl. J Pediatr Adolesc Gynecol 2004; 17(1): 35-37. Go to original source... Go to PubMed...
    10. Matsumoto Y, Yamamoto T, Isobe T, et al. Succesful treatment of vulvar lichen sclerosus in a child with low-concentration topical tacrolimus ointment. J Dermatol 2007; 34(2): 114-116. Go to original source... Go to PubMed...
    11. Böhm M, Frieling U, Luger TA, et al. Successful Treatment of Anogenital Lichen Sclerosus With Topical Tacrolimus. Arch Dermatol 2003; 139: 922-924. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.